SCHEMBL9258078

SCHEMBL9258078

O=C(/C=C(\S)c1ccc(C(=O)O)cc1)Nc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.54
TGM2 P21980 1/20 0.50
FFAR1 O14842 1/20 0.47
CYP1A2 P05177 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
DEGS1 O15121 1/20 0.46
MAOB P27338 2/20 0.46
EGFR P00533 1/20 0.46
MMP1 P03956 1/20 0.46
MMP2 P08253 1/20 0.46
MMP9 P14780 1/20 0.46
MAOA P21397 1/20 0.46
CA12 O43570 1/20 0.45
CA2 P00918 1/20 0.45
CA9 Q16790 1/20 0.45
KMT2A Q03164 4/20 0.45
MEN1 O00255 3/20 0.45
MAPT P10636 1/20 0.45
PTPN1 P18031 1/20 0.44
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9258086 1.00 ALDH1A1 (0.54) ALDH1A1TGM2FFAR1CYP1A2NPSR1
SCHEMBL9256850 0.95 FFAR1 (0.54) ALDH1A1TGM2FFAR1DEGS1CA12
SCHEMBL9256847 0.95 FFAR1 (0.54) ALDH1A1TGM2FFAR1DEGS1CA12
SCHEMBL9260712 0.80 NPC1 (0.60) ALDH1A1TGM2NPSR1DEGS1EGFR
SCHEMBL9260709 0.80 NPC1 (0.60) ALDH1A1TGM2NPSR1DEGS1EGFR
SCHEMBL10949923 0.79 FFAR1 (0.56) ALDH1A1TGM2FFAR1NPSR1DEGS1
SCHEMBL11839691 0.74 NAPRT (0.52) TGM2CYP1A2NPSR1DEGS1MAOB
SCHEMBL3659389 0.74 FFAR1 (0.79) ALDH1A1FFAR1KMT2AMEN1PTPN1
SCHEMBL1019968 0.74 EPHX2 (0.74) ALDH1A1FFAR1MAOBMAOAKMT2A
SCHEMBL10954608 0.73 NPC1 (0.55) ALDH1A1TGM2FFAR1NPSR1DEGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5411977-A Substituted 2,5-diaryl-4-isothiazolin-3-ones as antiinflammatory and antithrombotic agents THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1995-05-02 US disclosed